Distribution Solutions Group (NASDAQ:DSGR – Get Free Report) and Capstone Therapeutics (NASDAQ:CAPS – Get Free Report) are both small-cap industrials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership.
Valuation & Earnings
This table compares Distribution Solutions Group and Capstone Therapeutics”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Distribution Solutions Group | $2.05 billion | 0.78 | $8.35 million | $0.19 | 183.24 |
| Capstone Therapeutics | $48.11 million | 0.08 | -$21.23 million | ($3.35) | -0.06 |
Insider and Institutional Ownership
91.6% of Distribution Solutions Group shares are owned by institutional investors. Comparatively, 2.5% of Capstone Therapeutics shares are owned by institutional investors. 78.8% of Distribution Solutions Group shares are owned by insiders. Comparatively, 39.3% of Capstone Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Analyst Ratings
This is a summary of recent ratings and price targets for Distribution Solutions Group and Capstone Therapeutics, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Distribution Solutions Group | 0 | 4 | 0 | 0 | 2.00 |
| Capstone Therapeutics | 1 | 0 | 0 | 0 | 1.00 |
Distribution Solutions Group currently has a consensus target price of $35.00, indicating a potential upside of 0.53%. Given Distribution Solutions Group’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Distribution Solutions Group is more favorable than Capstone Therapeutics.
Risk & Volatility
Distribution Solutions Group has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Comparatively, Capstone Therapeutics has a beta of -1.52, indicating that its share price is 252% less volatile than the S&P 500.
Profitability
This table compares Distribution Solutions Group and Capstone Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Distribution Solutions Group | 0.44% | 9.33% | 3.41% |
| Capstone Therapeutics | -36.51% | -144.43% | -40.48% |
Summary
Distribution Solutions Group beats Capstone Therapeutics on 13 of the 13 factors compared between the two stocks.
About Distribution Solutions Group
Distribution Solutions Group, Inc., a specialty distribution company, engages in the provision of value-added distribution solutions in North America, Europe, Asia, South America, and the Middle East. The company provides its solutions to the maintenance, repair, and operations (MRO); original equipment manufacturer (OEM); and industrial technology markets. It operates through three segments: Lawson, Gexpro Services, and TestEquity. The Lawson segment distributes of specialty products and services to the industrial, commercial, institutional, and government MRO market. The TestEquity segment distributes test and measurement equipment and solutions, industrial and electronic production supplies, and vendor managed inventory programs, as well as converting, fabrication, and adhesive solutions under the TestEquity, Hisco, TEquipment, Techni-Tool, Jensen Tools, and Instrumex brands. The Gexpro Services segment provides supply chain management solutions that offer VMI, kitting, global logistics management, manufacturing localization and import expertise, value engineering, and quality assurance. The company was formerly known as Lawson Products, Inc. and has changed to Distribution Solutions Group, Inc. 2022 Distribution Solutions Group, Inc. was incorporated in 1952 and is headquartered in Fort Worth, Texas.
About Capstone Therapeutics
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
Receive News & Ratings for Distribution Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Distribution Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.
